Skip to main content

Korsana Biosciences, Inc.

KRSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001755237

No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Korsana Biosciences, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of KRSA: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders7168−3
Shares22.4M24.6M+2.22M (+9.9%)
Value$62.5M$96.0M+$33.5M (+53.6%)

New holders (17)

Institutions that held Korsana Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to KRSA in Q2 2021
InstitutionSharesValue% of portfolio
Pura Vida Investments, LLC507,489$1.98M0.14%
Millennium Management LLC389,041$1.52M0.00%
Susquehanna Fundamental Investments, LLC105,572$412.0K0.01%
Ergoteles LLC96,100$375.0K0.01%
Tibra Equities Europe Ltd85,000$332.0K0.10%
Diametric Capital, LP80,336$313.0K0.23%
HRT Financial LP65,158$254.0K0.00%
Prelude Capital Management, LLC50,104$195.0K0.01%
Marshall Wace, LLP28,863$113.0K0.00%
Prime Capital Investment Advisors, LLC22,250$87.0K0.01%
ExodusPoint Capital Management, LP21,563$84.0K0.00%
Cubist Systematic Strategies, LLC17,084$67.0K0.00%
Pinz Capital Management, LP5,500$21.0K0.01%
Clean Yield Group115$00.00%
Cutler Group LP200$00.00%
Advisory Services Network, LLC10$00.00%
Point72 Hong Kong Ltd121$00.00%

Sold out (20)

Institutions that held Korsana Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.